The Science,
Written Clearly.
Articles on cellular biology, longevity medicine, and the science behind each treatment programme. Written for patients who want to understand the basis of their treatment before deciding.
The Hallmarks of Ageing — What the Science Actually Says
Twelve defined biological processes drive cellular ageing. Understanding them is the first step to addressing them.
Read Article →
Autoimmunity and the Cellular Reset — What the Evidence Shows
Autoimmune conditions reflect an immune system that has lost its regulatory calibration. Cellular therapy is beginning to offer a path back.
Read Article →
The Case Against Donor Cells — Why Autologous Therapy Is Different
Most clinics administer cells banked from donors. Here is why that model has fundamental biological limitations — and why autologous therapy operates on different principles.
Read Article →
Joint Pain Is a Cellular Event — And It Can Be Addressed Cellularly
Cartilage degradation, synovial inflammation, and subchondral bone changes are biological processes — not simply mechanical wear. The distinction matters for treatment.
Read Article →
NAD+ at 40 — The Molecule Running Low When You Need It Most
NAD+ is central to cellular energy, DNA repair, and sirtuin activation. Its decline after 40 is measurable, consequential, and — importantly — addressable.
Read Article →
Skin Ageing Is Not Surface-Level — It Begins in the Fibroblast
The visible signs of skin ageing begin invisibly — in declining fibroblast activity, falling collagen synthesis, and the accumulation of senescent cells in the dermis.
Read Article →
What Happens in Our Laboratory — A Clinical Transparency Report
Our on-site GMP laboratory is what makes same-day autologous therapy possible. Here is a precise account of what happens inside it.
Read Article →
Why Bangkok — The Case for Southeast Asia's Medical Capital
Thailand has built one of Asia's most rigorous advanced therapy regulatory frameworks. The reasons are structural, not incidental.
Read Article →